default author photo

Emily Z. Keung

University of Texas MD Anderson Cancer Center - Department of Surgical Oncology

1400 Pressler Drive

P.O. Box 301402

Houston, TX 77230-1402

United States

SCHOLARLY PAPERS

1

DOWNLOADS

41

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma

Number of pages: 72 Posted: 18 Mar 2020
Mayinuer Maitituoheti, Emily Z. Keung, Ming Tang, Liang Yan, Hunain Alam, Guangchun Han, Ayush T. Raman, Christopher Terranova, Sharmistha Sarkar, Elias Orouji, Samir B. Amin, Sneha Sharma, Maura Williams, Neha S. Samant, Mayura Dhamdhere, Norman Zheng, tara shah, Amiksha Shah, Jacob B. Axelrad, Nazanin E. Anvar, Yu-Hsi Lin, Shan Jiang, Edward Q. Chang, Wei-Lien Wang, Davis R. Ingram, Alexander Lazar, Min Gyu Lee, Florian Muller, Linghua Wang, Haoqiang Ying and Kunal Rai
University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Surgical Oncology, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, Jackson Laboratory for Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center - Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center - Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, University of Texas at Houston - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology and University of Texas MD Anderson Cancer Center - Department of Genomic Medicine
Downloads 41 (1,170,409)
Citation 1

Abstract:

Loading...

Melanoma, KMT2D, Enhancer, Glycolysis, Chromatin, Epigenetics